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Oleoyl coenzyme A (OCoA)
1,2-dioleoyl-sn-glycerol (DOG)
Circular dichroism
FluorescenceDiacylglycerol acyltransferase 1 (DGAT1) catalyzes theﬁnal and dedicated step in the synthesis of triacylglycerol,
which is believed to involve the lipids oleoyl coenzymeA (OCoA) anddioleoyl-sn-glycerol (DOG) as substrates. In
this work we investigated the interaction of a speciﬁc peptide, referred to as SIT2, on the C-terminal of DGAT1
(HKWCIRHFYKP) with model membranes made with OCoA and DOG in Langmuir monolayers and liposomes.
According to the circular dichroism and ﬂuorescence data, conformational changes on SIT2 were seen only on
liposomes containing OCoA and DOG. In Langmuirmonolayers, SIT2 causes the isotherms of neat OCoA and DOG
monolayers to be expanded, but has negligible effect on mixed monolayers of OCoA and DOG. This synergistic
interaction between SIT2 and DOG+OCoAmay be rationalized in terms of amolecularmodel inwhich SIT2may
serve as a linkage between the two lipids. Our results therefore provide molecular-level evidence for the
interaction between this domain and the substrates OCoA and DOG for the synthesis of triacylglycerol.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Acyl-OCoA:diacylglycerol acyltransferase (DGAT) catalyzes the ﬁnal
step in triglyceride synthesis by facilitating the linkage of sn-1,2-
diacylglycerol (DAG) with a long chain acyl CoA. DGAT exists in two
primary isoforms, viz. DGAT1 and DGAT2 [1]; DGAT1 is most highly
expressed in the small intestine and white adipose tissues, whereas
DGAT2 is primarily expressed in the liver and white adipose tissues [1]
where its expression is insulin-responsive. There is some evidence that
the two enzymes play different roles in triglyceride metabolism. The
relationship between protein structure and function in DGAT/ACAT
family is still not well established owing due to the difﬁculty in isolating
DGAT1 because of its hydrophobic character. Using a prediction domain
model, Cases et al. [1] identiﬁed nine transmembrane domains and a
conserved serine necessary for ACAT activity. Little is known about the
DGAT1 regions involved in substrate interaction, apart from the fact that
the FYXDWWN motif, highly conserved in all DGAT/ACAT family
members, has been implicated in binding fatty Acyl CoA [2]. However,
experimental evidence has emerged suggesting that the fatty acyl-CoA
binding domain is at the N-terminus [3,4]. Also, toward the C-terminal).
ll rights reserved.region DGAT1 possesses a putative diacylglycerol binding domain
(HKWCIRHFYKP) as in protein kinase C and diacylglycerol kinases [5,6].
In order to evaluate this putative binding site in the bovine DGAT1
(NP_777118.1), we studied the interaction between the peptide
corresponding to residues 379–393, denoted SIT2, with the phospho-
lipids oleoyl coenzyme A (OCoA) and dioleoyl-sn-glycerol (DOG)
since they are the natural substrates for the enzyme. Such an inter-
action was mimicked with membrane models comprising Langmuir
monolayers [7–12] and liposomes [13–15].
The use of these membrane models to investigate the action of
pharmaceutical drugs and biomolecules has been motivated by the
fact that the structural framework of a cell membrane comprises a
phospholipid bilayer [16] and by the difﬁculties in performing
experiments with cell membranes in vivo. In spite of the obvious,
severe simpliﬁcations, useful information can be inferred from such
simple models. Indeed, one may correlate the location of a drug in a
Langmuir monolayer with the pharmacological activity [17], espe-
cially in cases where penetration into the membrane is relevant for
the activity. It is also possible to obtain molecular-level evidence for
complexation of proteins and polysaccharides in the membrane, as is
the case of chitosan that was shown to remove β-lactoglobulin from
Langmuir monolayers of negatively charged phospholipids [18].
Liposomes and monolayers are complementary in terms of
obviating the simpliﬁcations of membrane models. On one hand,
liposomes are adequate for mimicking a bilayer and study transport
Fig. 1. Surface pressure–area isotherms of DOG/SIT2 monolayers containing different
peptide concentrations: (solid) pure DOG, (dashed) 0.1 mol%, (dotted) 0.5 mol%,
(dashed–dotted) 1 mol% and (dashed–dotted–dotted) 5 mol% of SIT2 in the monolayer.
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the other hand, the method with Langmuir monolayers allows control
of molecular packing, which is essential for monitoring effects from
guest molecules, including drugs, proteins and peptides [19–24].
Circular dichroism (CD), ﬂuorescence emission and surface
pressure–area isotherms were used to understand the SIT2 peptide–
membrane model interaction and the possible biological implications
are commented upon in the Final remarks.
2. Experimental procedures
2.1. Materials
SIT2 (residues 379–393 from bovine DGAT1, NP_777118.1) was
synthesized by Bio Synthesis, Inc.(with ≥95% purity). According to
the protparam program [25], the sequence is NIPVHKWAIR HFYKP,
with 15 amino acids, molecular weight of 1906.2 Da and theoretical pI
of 10.29. There is no net number of negatively charged residues (Asp+
Glu) and the total number of positively charged residues (Arg+Lys) is
3. To prevent any interpeptide disulﬁde bond formation, the residue
Ala was placed instead of the original, but not conserved amongst the
ACAT family [5], Cys386. The phospholipids oleoyl coenzyme A
(OCoA), 1,2-dioleoyl-sn-glycerol (DOG), 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC) and dipalmitoyl phosphatidyl glycerol
(DPPG) were purchased from Avanti Polar Lipids and were used
without further puriﬁcation.
2.2. Langmuir monolayers
Langmuir monolayers were formed by spreading the phospholipids
andpeptide solutions in organic solvents (see below) onto the surface of
an ultrapurewater subphase, supplied by aMilli-Ro coupled to aMilli-Q
system (MilliPore). The isotherm experimentswere carried out in a KSV
5000 Langmuir trough in a class 10,000 clean room, with the subphase
temperature kept at 22 °C using a thermostatted bath (Neslab).
Equimolar solutions of phospholipids (DOG, OCoA, DPPC and DPPG)
and peptide were dissolved in chloroform and methanol, respectively.
An aliquot with 100 µL of DOG/SIT2, OCoA/SIT2 or DOG/OCoA/SIT2
mixtures, in different relative concentrations of the peptide, were
spread onto the surface. After 15 min elapsed for evaporation of the
solvent, the monolayers were compressed at a speed of 10 mm/min.
Surface pressures were measured with a Wilhelmy plate provided by
KSV (Finland).
2.3. Liposomes
Four compositions of liposomes were obtained with DPPC, DPPC/
OCoA (9:1), DPPC/DOG (9:1) and DPPC/DOG/OCoA (9:1/2:1/2). The
phospholipids (1 mM) were dissolved in chloroform and SIT2 peptide
(0.02 mM) dissolved in methanol. The chloroform and/or methanol
were evaporatedusing liquid nitrogenuntil a thinﬁlmhadbeen formed.
The phospholipids and peptide were dried together. After complete
evaporation of the solvents, the ﬁlm was hydrated using 1 mL of pre-
heated (40 °C, during 2 h) phosphate buffer solution (10 mM, pH 7.5).
This mixture was then mixed in a vortex where multilamellar vesicles
(MLVs)were formed. The liposomeswere obtained by aMLVs extrusion
process through polycarbonate membranes with 100 nm pores to
decrease dispersity in size and formation of the unilamellar vesicles,
before the spectroscopy analysis.
2.4. Far-UV circular dichroism (CD) measurements
Far-UV CD measurements were performed using SIT2 peptide
(0.02 mM in 10 mM phosphate buffer, pH 7.5) on its own or
incorporated into liposomes solutions. Measurements were carried
out in the far-UV range (195–250 nm) at 25 °C with a Jasco J-715spectropolarimeter (JASCO Corporation, Japan) using a cylindrical
0.1 cm path quartz cuvette. The CD spectra of the solvent were sub-
tracted to eliminate backgroundeffects and the spectrawere acquiredas
an accumulation of 16 runs.
2.5. Steady-state ﬂuorescence
The steady-state ﬂuorescence emission measurements were
performed at 25 °C, in an ISS K2 spectroﬂuorimeter (ISS, Illinois,
USA) using a rectangular 1 cm quartz cuvette. SIT2 samples in 10 mM
phosphate buffer pH 7.5, with or without liposomes, were excited at
280 nmwith a 2 mm slit, and the emissionwasmonitored from 295 to
450 nm with a 0.5 mm slit.
3. Results and discussion
In this work we evaluate a DGAT1 region (comprised by SIT2) as a
promising region to be involved in the binding of diacylglycerol. This
was performed by studying the interaction between SIT2 and
Langmuir monolayers or liposomes made with the lipids DOG and
OCoA. For comparison, experiments with SIT2 and DPPC will also be
described.
3.1. Langmuir monolayers
The interaction between SIT2 and DOG and OCoA was studied in
Langmuir ﬁlms obtained by co-spreading SIT2 with the lipids. Fig. 1
shows the surface pressure–area isotherms for DOG monolayers
containing different SIT2 percentages (0.1; 0.5; 1 and 5 mol%). The
pure DOG monolayer, whose molecules are not charged at a neat air/
water interface, displays an extrapolated area of ca. 120 Å2. SIT2
caused the isotherms to be considerably expanded, i.e. shifted to
larger areas per molecule, with an increase in area per DOG molecule
at a ﬁxed pressure that may reach 50 Å2. The incorporation of SIT2
caused the collapse pressure to increase in comparison with the neat
DOG monolayer. Here we employ the area per DOG molecule rather
than the area per molecule (considering that it is a mixedmonolayer),
which means that all the calculations are made as if only the DOG
molecules were at the interface. With such a choice, all changes
caused in packing of the DOG molecules or caused by insertion of the
guest molecules are readily seen. The trend of increasing expansion
for increasing SIT2 concentration is broken for concentrations above
1 mol% (5 mol% of SIT2). This effect has been observed with another
peptide [26], and is probably due to peptide saturation. The observed
saturation at a few percent of the peptidemeans that large amounts of
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may be a cooperative interaction (see comment later on), as a
measurable effect occurs at very small concentrations of the peptide.
In control experiments it was noted that SIT2 on its own cannot
form a monolayer as most of the material spread goes into the
subphase. The coupling with DOG monolayer reinforces SIT2 as a
diacylglycerol binding site, for it interacts with the uncharged DOG
even though it is positively charged. We have also performed several
cycles of compression and decompression with the monolayers and
noted that there was no signiﬁcant change in the isotherms between
consecutive cycles. Therefore, even if the SIT2 molecules were
expelled from the interface at high pressures, they were not dissolved
into the subphase in signiﬁcant amounts; otherwise the subsequent
surface pressure isotherm would differ from the previous one.
There was another important change in the isotherms upon
incorporation of SIT2, namely the appearance of further plateaus. For
the pure DOG monolayer, the isotherm is relatively condensed and a
long plateau appears at ca. 36–37mN/m, which is probably due to
collapse. For the isotherms containing 1 mol% or less, there was also
only one plateau since there was much less peptide incorporated in
the monolayer. In contrast, in the presence of a larger amount of SIT2
another phase transition occurs, as indicated in Fig. 2A. This result has
been rationalized with a scheme shown in Fig. 2B, for an isothermFig. 2. (A) Surface pressure isotherm depicting the possible steps in peptide
conformation in a DOG monolayer, which are depicted in the scheme of ﬁgure (B).with 5 mol% SIT2 reproduced in Fig. 2A. In Step 1, the peptide would
be located in the hydrophobic region of the DOG molecules. In Step 2
the peptide is assumed to be in contact with the DOG polar head and
the aqueous subphase. Therefore, the area occupied by one DOG
molecule in the monolayer containing SIT2 is roughly the same as that
for a pure DOGmonolayer. The incorporation of the peptide is induced
by the lateral pressure exerted on the monolayer, in a reversible
process as subsequent surface pressure–area isotherms are identical
to the ﬁrst one. Note also that the distinct isotherms mean that some
of the peptides were not excluded from the interface.
Small quantities of SIT2 were also found to affect OCoA monolayers,
as illustrated in Fig. 3. Again, the incorporation of the peptide induces
isotherm expansion. For instance, the extrapolated area for a pure OCoA
monolayer was ca. 40 Å2, but it increased to ca. 90–100 Å2 with 5 mol%
of SIT2. Furthermore, for SIT2 concentrations above 0.5 mol%, a phase
transition appeared at high pressures. Signiﬁcantly, for closely packed
monolayers (i.e. high pressures), all isotherms seem to coincide, which
means that SIT2 molecules were expelled from the interface. Because
OCoA is negatively charged and SIT2 is positively charged, one could
expect a much stronger interaction than between SIT2 and DOG.
However, the differences are not so large, and therefore one concludes
that the interaction may also occur via other types of forces, such as
hydrophobic and H-bonding.
The ability of incorporation into the monolayers appears to be
different for DOG and OCoA. For the OCoA monolayer, whose molecule
occupies a smaller area per molecule, forming a more organized ﬁlm
(more closely packed), a higher amount of SIT2 could be incorporated,
and saturation was not reached up to 5 mol%. A visual inspection of the
isotherms for 1 and 5 mol% in Fig. 3, however, appears to indicate that
saturationwouldeventually be reached. TheDOGmolecules, in contrast,
occupy a much larger area at the interface, which points to a less
organized ﬁlm. This did not allow insertion of a high amount of SIT2,
thus accounting for a saturation at a lower concentration. Because
the insertion of SIT2 into the monolayers – and the ﬁlm organization as
well – depends on various intermolecular forces, it is not possible to
determine the precise causes for the differences.
A surprising result was observed for the interaction between SIT2
and mixed monolayers of DOG and OCoA, spread at the air/water
interface with the same molar concentration (1:1). Fig. 4 shows that
incorporation of SIT2 in 3 concentrations did not cause any signiﬁcant
change in the isotherms. Probably with both lipids (DOG and OCoA) in
equal proportions at the interface, SIT2 cannot penetrate into the
hydrophobic region, remaining in contact with the water subphase, asFig. 3. Surface pressure–area isotherms of OCoA/SIT2 monolayers containing various
SIT2 concentrations: (solid) pure OCoA, (dashed) 0.1 mol%, (dotted) 0.5 mol%, (dashed–
dotted), 1 mol% and (dashed–dotted–dotted), 5 mol% of SIT2 in the monolayer.
Fig. 4. Surface pressure–area isotherms of DOG/OCoA/SIT2 monolayers, for 1:1
concentration of DOG and OCoA, containing different peptide concentrations: (solid)
pure DOG/OCoA, (dashed) 0.5 mol% and (dotted) 1 mol% of SIT2 in the monolayer. The
inset shows the suggested location for SIT2, which was based on the experimental
evidence and not on molecular modeling.
2323D.T. Talhari et al. / Biochimica et Biophysica Acta 1788 (2009) 2320–2325indicated in the scheme shown in the inset of Fig. 4. The suggestion
for the location of SIT2 was based on the identical isotherms for neat
DOG+OCoA monolayers and mixed monolayers containing distinct
amounts of SIT2. Such results canonly be explained if SIT2 is either at the
periphery of the headgroups or expelled into the subphase. Since we
have evidence to suggest that SIT2 did not dissolve into the subphase in
signiﬁcant amounts, for consecutive compression–decompression
cycles led to similar isotherms, the most probable positioning is at the
periphery of the headgroups.
We have also investigated the effects from adding SIT2 to mixed
DOG+OCoA monolayers with various relative concentrations of DOG.
Fig. 5 shows surface pressure isotherms for thesemixedmonolayers at a
ﬁxed concentration of 2% for SIT2. As expected, the effect from SIT2 is
negligible for a 1:1 DOG:OCoA mixture, consistent with the results in
Fig. 4. However, for the other concentrations, SIT2 caused the isotherms
to be less expanded than for the corresponding mixed monolayer.
Therefore, while SIT2 expanded both neat DOG and neat OCoA
monolayers (cf. Figs. 1 and 3), it induced condensation for monolayers
with small proportions of DOG in OCoA or small proportions of OCoA in
DOG. The latter observation is better visualized in Fig. 6. This is probablyFig. 5. Surface pressure–area isotherms for DOG/OCoA/SIT2 mixedmonolayers at a ﬁxed
concentration of 2% for SIT2 with various relative concentrations of DOG/OCoA: (solid
black) 1:0, (dashed black) 9:1, (dotted black) 3:1, (dashed dotted gray) 1:1, (dotted light
gray) 1:3, (dashed light gray) 1:9 and (solid light gray) 0:1 ofDOG:OCoA in themonolayer.because SIT2 reduces the repulsive interactions betweenOCoA andDOG
in the mixed monolayers; such repulsion leads to the super linear
behavior in the area per molecule vs. DOG concentration for small and
large DOG proportions in Fig. 6.
Taken all the above results together, one concludes that there is
synergy in the interaction between SIT2 and DOG+OCoAmolecules, as
the presence of DOG (or OCoA) prevents SIT2 molecules from being
incorporated into the hydrophobic region of OCoA (or DOG) molecules.
For unequal proportions of OCoA and DOGmolecules, in addition to the
absence of incorporation, SIT2 even caused condensation of the
monolayer by reducing the repulsion between OCoA and DOG. The
term “synergistic interaction” has been used in the literature to express
that the effect from twoormore factors is not the superimposition of the
effects from the factors in separate. In our work, the synergy is clear in
that the expansions caused by SIT2 on DOG and OCoA – when
interacting with either of the neat monolayers – simply vanish when
SIT2 interacts with the 1:1 mixed monolayer (DOG+OCoA). This
concept of synergy does not require cooperativity, even though in our
measurements there is cooperativity in the interaction of SIT2with both
OCoAandDOG, as very small amounts of SIT2were sufﬁcient to produce
a measurable effect on the isotherms.
In subsidiary experiments, we also veriﬁed the interaction of SIT2
with DPPC and DPPG monolayers, two phospholipids present in
abundance in cell membranes, one zwiterionic and another negatively
charged. Some expansion in the DPPC isothermwas observed in Fig. 7A,
which affected the phase transition from the liquid-expanded to the
liquid-condensed state. This phase transition is attributed to the
orderingof thehydrocarbon chainsuponcompressionof themonolayer,
and the long plateau appears because there is a signiﬁcant decrease in
the area occupied by each molecule as the liquid-condensed state is
reached with the chains ordered. SIT2 affected the monolayer in two
ways. First, a higher energy is required for inducing order in the chains,
which is reﬂected in larger surface pressures for the phase transition.
Second, this transition is not as well deﬁned as in neat DPPC, probably
owing to somedisrupting of themonolayer. The changes caused by SIT2
on DPPC were nevertheless much smaller than on DOG, which is also
uncharged. At high pressures, in particular, the isotherm was the same
as for a DPPC monolayer. Fig. 7B indicates that SIT2 induced only small
changes in the isotherms of DPPG, considerably smaller than for OCoA
and DOG. At low pressures, there was a very slight increase in area per
molecule, while in the liquid-condensed phase the area was even
smaller than for the neat DPPG monolayer. The results with DPPC andFig. 6. Area per molecule for mixed monolayers with various relative concentrations of
DOG:OCoA in the absence (■) and presence (●) of SIT2 2 mol% at the pressure of 20 mN/
m. The black and red lines were drawn only to guide the eyes.
Fig. 7. Surface pressure–area isotherms of (A) DPPC/SIT2 and (B) DPPG/SIT2
monolayers containing different peptide concentrations: (solid) pure phospholipid,
(dashed) 0.5 mol% and (dotted) 1 mol% of SIT2 in the monolayer.
Fig. 8. Circular dichroism (A) and ﬂuorescence emission (B) spectra of SIT2 peptide in
liposomes. SIT2 only (solid) and in liposomes: DPPC/OCoA (dashed), DPPC/DOG
(dotted), DPPC (dashed–dotted) and DPPC/OCoA/DOG (dashed–dotted–dotted).
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the electrostatic play an important role, and points to a speciﬁc, strong
interaction between SIT2 and DOG.3.2. Liposomes
The interaction of SIT2 with lipid bilayers was studied with
liposomes containing different proportions of phospholipids to mimic
physiological conditions. Fig. 8A shows theCD spectra of SIT2 in solution
andwithin various types of liposomes. For SIT2 in aphosphate buffer, pH
7.5, the spectrum displayed a minimum at 197 nm compatible with a
disordered structure, as frequently reported for several peptides in
solution [27]. For SIT2 in thepresence ofDPPCandDPPC/DOG liposomes
the spectra were similar to that in solution, for SIT2 probably did not
bind to the liposomes or its structure was not changed upon
incorporation in the bilayer. Since the liposomes are in a dominant gel
phase state, SIT2 may adsorb at the surface but is not inserted in the
bilayer. In thepresence ofDPPC/OCoAandDPPC/OCoA/DOG liposomes,
however, SIT2 showed conformational change typical of proteins
containing alpha and beta structures with minima at 209–216 nm
(Fig. 8A). The most signiﬁcant ordering was observed for SIT2 in DPPC/
DOG/OCoA liposomes. This may help explain why it may interact
with lipids but not change conformation signiﬁcantly. For the sake of
comparison, we have also tried to produce liposomes with neat DOG or
neatOCoA, but they couldnot beobtained, probablybecause theyhave3
and 1 chains, respectively, which makes it difﬁcult to obtain liposomes.The ﬂuorescence emission spectra of SIT2 in Fig. 8B are consistent
with the CD results. The spectra for SIT2 in solution and in DPPC and
DPPC/DOG liposomes were similar with an emission maximum at ca.
350 nm, typical of Trp residues exposed to the solvent. The decrease in
intensity is attributed to quenching caused by scattering from the
liposomes. In contrast, the ﬂuorescence spectra of SIT2 in DPPC/OCoA
andDPPC/OCoA/DOG liposomes showedblue shifts of 5 nmand22 nm,
respectively (Fig. 8B). The quenching is again due to scattering by
liposomes. One could in principle eliminate the effect from scattering
using a control experiment with free Trp rather than the peptide (See
FEBS Journal 274 (2007) 5096–5104) [28], which was not possible here
because free Trp already gives a higher ﬂuorescence intensity.
Nevertheless, part of the scattering was taken into account by consid-
ering the SIT2-free liposomes. Therefore, the results with liposomes
conﬁrm the synergistic interaction between SIT2 and OCoA+DOG
molecules, as in the Langmuir monolayers. The interactions will prob-
ably be electrostatic and van der Waals, though their precise nature
cannot be determined with the present data.
4. Final remarks
The combined use of Langmuir monolayers and liposomes as
simpliﬁed membrane models has been useful to investigate the
interaction between the peptide SIT2 and the lipids OCoA and DOG.
From the surface pressure isotherms, SIT2 was found to expand both
2325D.T. Talhari et al. / Biochimica et Biophysica Acta 1788 (2009) 2320–2325OCoA and DOG monolayers, but the same did not apply when the
monolayer contained OCoA and DOG molecules in equal proportions.
In the latter case, SIT2 could not penetrate into the hydrophobic
region of the mixed monolayer. This was interpreted as due to a
synergy in the interaction between SIT2 and OCoA and SIT2 and DOG,
which also occurred in liposomes. In the CD spectra, the minima at
209–216 nm characteristic of ordered SIT2 (i.e. exhibiting alpha
helices) is seen for the liposomes containing both OCoA and DOG, but
not in the other cases. Similarly, in the ﬂuorescence spectra, a large
shift was only observed for SIT2 incorporated into liposomes that
contained OCoA and DOG. Taken together, our results suggest that a
speciﬁc C-terminal peptide (SIT2) of DGAT1 interacts with OCoA and
DOG in such a way as to possibly bring together these substrates to
allow for the catalytic reaction yielding triacylglycerol.
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